| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ANTX | AN2 Therapeutics, Inc. | Director | $16.8K | Oct 10, 2025 | ||
| LPTX | LEAP THERAPEUTICS, INC. | Director | Nov 11, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|